HSIC
HENRY SCHEIN INC
NASDAQ · Healthcare · Medical - Distribution · US
$84.84
−0.24%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $1.34
- Revenue estimate
- $3.5B
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $1.27
- EPS estimate
- $1.24
- Revenue actual
- $3.5B
- Revenue estimate
- $3.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +6.0%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $99
- PT range
- $85 – $112
- Analysts
- 6
4 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $1.24 | $1.27 | Beat 2.42% | $3.5B |
| May 5, 2026 | $1.20 | $1.32 | Beat 10.00% | $3.4B |
| Feb 24, 2026 | $1.30 | $1.34 | Beat 3.08% | $3.4B |
| Nov 4, 2025 | $1.27 | $1.38 | Beat 8.66% | $3.3B |
| Feb 25, 2025 | $1.23 | $1.19 | Miss -3.25% | $3.2B |
| Feb 27, 2024 | $0.70 | $0.66 | Miss -5.71% | $3.0B |
| Nov 13, 2023 | $1.32 | $1.32 | In line | $3.2B |
| Feb 16, 2023 | $1.21 | $1.21 | Beat 0.17% | $3.4B |
| Nov 1, 2022 | $1.14 | $1.09 | Miss -4.39% | $3.1B |
| Aug 2, 2022 | $1.16 | $1.16 | In line | $3.0B |
| May 3, 2022 | $1.19 | $1.30 | Beat 9.24% | $3.2B |
| Feb 15, 2022 | $0.91 | $1.07 | Beat 17.58% | $3.3B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026